Pharmafile Logo
Pharmafocus logo
Advanced Search

Mergers and Acquisitions

Showing 15 posts of 36 posts found.

BioPhorum announces acquisition of Inspired Pharma

December 15, 2025 Mergers and Acquisitions BioPhorum, Inspired Pharma

BioPhorum, a global pharmaceutical collaboration group, has announced the acquisition of Inspired Pharma, a provider of specialist pharmaceutical training. The …
News

Er-Kim to distribute CNX Therapeutics’ oncology drugs across Europe and Turkey

August 29, 2025 Logistics & Distribution, Manufacturing and Production, Mergers and Acquisitions CNX Therapeutics, Corporate, Er-Kim, Oncology, central nervous system disorders, critical care

Turkish pharma company, Er-Kim, has signed a distribution agreement with CNX Therapeutics to expand access to a portfolio of oncology …
News
handshake-2056023_960_720

Terumo to acquire Oxford spin-out OrganOx in $1.5b deal

August 26, 2025 Mergers and Acquisitions Corporate, OrganOx, Terumo, University of Oxford, organ transplantation

Japanese medical technology company Terumo has announced it will acquire OrganOx, a University of Oxford, UK, spin-out specialising in organ …
News

BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation

August 19, 2025 Mergers and Acquisitions, Research and Development BioMed X, Novo Nordisk, Pharmacy, drug development, therapeutic peptides

BioMed X has announced a new collaboration with Novo Nordisk to improve oral delivery of therapeutic peptides – a major …
News
partnership

IQVIA and Veeva agree long-term partnerships to support service delivery

August 19, 2025 Mergers and Acquisitions Corporate, IQVIA, Veeva Systems

IQVIA and Veeva Systems have announced the formation of global partnerships covering clinical and commercial services. IQVIA provides advanced analytics, …
News

Enzybel Pharma 2 and Deebio partner to address pancrelipase shortages

August 15, 2025 Manufacturing and Production, Mergers and Acquisitions Deebio, Enzybel Pharma 2, Gastrointestinal tract, Natix, pancrelipase

Enzybel Pharma 2, part of European distributor Natix, has formed an alliance with Chinese enzyme manufacturer Deebio to help alleviate …
News

Sandoz signs renewable energy deal to supply 90% of European operations

August 13, 2025 Mergers and Acquisitions Corporate, Elawan Energy, Sandoz, decarbonisation, renewable energy

Sandoz has entered into a ten-year virtual Power Purchase Agreement with Elawan Energy for the development of new solar projects …
News
handshake-1910702_960_720

Sartorius Stedim Biotech partners with Nanotein Technologies to develop cell therapy manufacturing

August 12, 2025 Mergers and Acquisitions Corporate, Nanotein Technologies, Sartorius Stedim Biotech, cell therapy, gene therapy

Sartorius Stedim Biotech has partnered with Nanotein Technologies to expand access to immune cell activation reagents for cell therapy manufacturing. …
News

Horus Pharma expands distribution in North Africa and the Middle East

August 8, 2025 Mergers and Acquisitions, Research and Development Corporate, Horus Pharma, Opthalmology, distribution agreement

Ophthalmology company, Horus Pharma, based in Nice, France, has extended its global presence through new distribution agreements across eight countries …
News
sanofi

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline

August 6, 2025 Mergers and Acquisitions Alzheimer's disease, Corporate, Neurology, Sanofi, Vigil Neuroscience, neurodegenerative diseases

Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology company specialising in neurodegenerative diseases. …
News

Polpharma Biologics and Fresenius Kabi partner to develop treatment for ulcerative colitis and Crohn’s disease

August 5, 2025 Mergers and Acquisitions Corporate, Crohn’s disease, Fresenius Kabi, Gastrointestinal tract, Polpharma Biologics, ulcerative colitis

Polpharma Biologics has signed a global licensing agreement with Fresenius Kabi for the commercialisation of PB016, a proposed biosimilar to …
News

ESTEVE expands into US market with acquisition of Regis Technologies

August 1, 2025 Mergers and Acquisitions Corporate, ESTEVE, Pharmacy, Regis Technologies, US pharma market, contract development and manufacturing organisation

ESTEVE (Esteve Química), based in Barcelona, Spain, has acquired Regis Technologies, a contract development and manufacturing organisation (CDMO) based in …
News

BioDuro and Atombeat partner to accelerate AI-powered peptide drug discovery

July 31, 2025 Mergers and Acquisitions AI, BioDuro, Corporate, Devices

BioDuro and Atombeat have announced a partnership to launch an artificial intelligence (AI)-driven platform designed to accelerate peptide drug discovery …
News
laboratory-testing-az

Clinisys acquires Orchard Software to expand laboratory informatics leadership

July 30, 2025 Analytical & Laboratory Services, Mergers and Acquisitions, Research and Development Clinisys, Corporate, Francisco Partners, Orchard Software, laboratory informatics, laboratory information management systems

Clinisys has announced the acquisition of Orchard Software from Francisco Partners, strengthening its position in laboratory informatics. The strategic acquisition …
News

ViroCell Biologics and AvenCell Therapeutics partner to accelerate allogeneic CAR-T therapy development

July 29, 2025 Contract Manufacturing, Manufacturing Services, Mergers and Acquisitions, Research and Development AvenCell Therapeutics, CAR-T therapy, Contract Development Manufacturing Organisation, Good Manufacturing Practice, Immunology, Oncology, ViroCell Biologics, autoimmune diseases, blood cancer

ViroCell Biologics has announced a new manufacturing collaboration with AvenCell Therapeutics to produce a high-yield retroviral vector supporting the clinical …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025